August 14, 2017 09:22 AM EDT
Pharma

Mer­ck CEO Ken Fra­zier re­signs from Trump coun­cil in protest, and the pres­i­dent swift­ly bites back

John Carroll

Editor & Founder

Mer­ck CEO Ken Fra­zier, the on­ly African-Amer­i­can run­ning a top glob­al bio­phar­ma com­pa­ny, has very pub­licly bro­ken with Pres­i­dent Trump, re­sign­ing in protest from the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

To lead NIH, Trump taps Stan­ford aca­d­e­m­ic and pan­dem­ic re­sponse crit­ic Jay Bhat­tacharya

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

A service from the Financial Times